Dedicated to
Diagnostics

Alliance Medical lead the way in high-quality diagnostic imaging. For over 30 years, our experts have combined service excellence and innovation to improve patient access, experiences and outcomes.
220 +
facilities across
Europe
4,000,000 +
procedures carried out
per annum
250,000 +
radiopharmaceutical doses delivered per annum
4000 +
team
members

Alliance Medical
around the world 

Alliance Medical operates in various locations worldwide, including the UK, Ireland, Italy, Northern Europe and Saudi Arabia.

Our global footprint ensures that patients and clinicians worldwide benefit from our leading diagnostic imaging services. Our extensive network offers better access to leading technology and innovation and fosters collaboration within multiple healthcare landscapes.

Your trusted partner
for Community
Diagnostic Centres

As the front-runner in CDC provision, we created the UK’s first community diagnostic centre. We now operate 8 multimodality CDCs across the UK; and 35 CDCs in Italy. We’re trusted to meet your diagnostic challenges - whether that's small-scale spokes or large, multimodality sites.

Radiopharmacy 

Alliance Medical's radiopharmaceutical production sites are critical to diagnostic imaging. These sites are responsible for producing radiopharmaceuticals used in PET and SPECT scans to diagnose and monitor various medical conditions, including cancer, heart disease, and neurological disorders.

Mobile solutions

Our mobile MRI, CT and PET-CT solutions have proven to reduce waiting lists and maximise patient throughput; whilst delivering an excellent patient experience.

PET-CT 

As a leader in molecular imaging, we are consistently improving accessibility and cancer pathways by investing in PET-CT and introducing new digital PET-CT scanners at our centres.

Find out more about Alliance Medical 

Established in 1989, we are a trusted NHS partner in the UK, an award-winning provider of community diagnostic centres and holders of the national contract for PET-CT in England; as well as offering a comprehensive private patient provision worldwide.

With 12 radiopharmaceutical production facilities and an investment exceeding £100 million in PET-CT, we stand at the forefront of advanced diagnostic solutions.

We operate across the UK, Ireland, Italy, Northern Europe and Saudi Arabia employing over 4000 experienced professionals who share a steadfast dedication to diagnostics.